Bovine Plasma Market, by Grade (Technical and Standard), by Origin (U.S., Australia, New Zealand, and Others (Brazil, Mexico, etc.)), by Application (Cell Culture Media, Vaccine Production, Drug Discovery, and Others (Forensic Studies, in vitro diagnostic

Bovine Plasma Market, by Grade (Technical and Standard), by Origin (U.S., Australia, New Zealand, and Others (Brazil, Mexico, etc.)), by Application (Cell Culture Media, Vaccine Production, Drug Discovery, and Others (Forensic Studies, in vitro diagnostics, etc.)), by End User (Biopharmaceutical Industry, Academic & Research Institutes, and Others (Diagnostic Laboratories, Forensic Laboratories, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Bovine plasma is extracted from animals belonging to the family Bovidae. This family includes not only cows but goats, sheep, bison and buffalo. Bovine plasma is the liquid component of the whole blood, which is free of cells and cellular debris. It is yellow in color due to presence of bilirubin. It is generally collected from the commercial slaughterhouse from cattle. It has wide range of applications in vaccine production, manufacturing of cell culture media, drug discovery and forensic studies. Bovine blood plasma derivatives are products containing proteins that are obtained from the blood plasma of bovine animals using physico-chemical or other fractionation processes.

Bovine blood plasma include, Factor VIII and IX Concentrate, Anti-Inhibitor Coagulation Complex (AICC), Albumin, immunoglobulins, including Rh Immune Globulin, Anti-Thrombin III Concentrate, and Alpha 1-Proteinase Inhibitor Concentrate. Plasma derivatives are used for protein structure analysis, sequence analysis, and biochemical research. Bovine blood plasma derivatives such as plant-extractable proteins and other artificial nutrient components are exceptional One of the most often used commercially accessible bovine derived protein fractions is bovine immunoglobulin G (IgG).

Market Dynamics

Increasing adoption of inorganic strategies by key players in market such as acquisitions is expected to drive the market growth over the forecast period. For instance, on April 3, 2022 ANZCO Foods, a New Zealand-based manufacturer and supplier of animal serum, proteins and plasma, owned by a Japan-based company Itoham Foods, extended its healthcare capacity with acquisition of a biotech company Moregate Biotech. Moregate biotech is a biotech company that supplies animal by products such as animal sera, protein, and plasma.

Key features of the study: This report provides in-depth analysis of the global bovine plasma market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players It profiles key players in the global bovine plasma market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies Key companies covered as a part of this study include Thermo Fisher Scientific, Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals, Bovogen Biologicals Pty Ltd, Biowest, Internegocios S.A., ROCKY MOUNTAIN BIOLOGICALS, Sonac, Innovative Research, Lake Immunogenics., Canvax Reagents S.L., Merck KGaA, Cambridge Bioscience Limited.Bio-Techne, VWR International, LLC., Otto Chemie Pvt. Ltd., BioVision Inc, Pel-Freez, LLC, Canvax Reagents S.L., GeneTex, Inc, Cygnus Technologies, Equitech-Bio, and 3H Biomedical AB Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics The global bovine plasma market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bovine plasma marketDetailed Segmentation: Global Bovine Plasma Market, By Grade:TechnicalStandard Global Bovine Plasma Market, By Origin: U.S.AustraliaNew ZealandOthers (Brazil, Mexico, etc.) Global Bovine Plasma Market, By Application:Cell Culture MediaVaccine ProductionDrug DiscoveryOthers (Forensic Studies, in vitro diagnostics, etc.) Global Bovine Plasma Market, By End User: Biopharmaceutical IndustryAcademic & Research InstitutesOthers (Diagnostic Laboratories, Forensic Laboratories, etc.) Global Bovine Plasma Market, By Region:North AmericaBy CountryU.S.CanadaLatin AmericaBy CountryBrazilMexicoArgentinaRest of Latin AmericaEuropeBy CountryGermanyU.K.FranceItalySpainRussiaRest of EuropeAsia PacificBy CountryChinaIndiaJapanAustraliaSouth KoreaASEANRest of Asia PacificMiddle EastBy CountryGCCIsraelRest of Middle EastAfricaBy Region/CountrySouth AfricaCentral AfricaNorth Africa Company ProfilesThermo Fisher Scientific *Company HighlightsProducts PortfolioKey HighlightsFinancial PerformanceStrategiesMoregate BioTechGeminiAtlanta BiologicalsTissue Culture BiologicalsBovogen Biologicals Pty LtdBiowest, Internegocios S.A.,ROCKY MOUNTAIN BIOLOGICALSSonacInnovative ResearchLake Immunogenics.Canvax Reagents S.L.Merck KGaACambridge Bioscience LimitedBio-TechneVWR International, LLC.Otto Chemie Pvt. Ltd.BioVision IncPel-Freez, LLCCanvax Reagents S.L.GeneTex, IncCygnus TechnologiesEquitech-Bio3H Biomedical AB “*” marked represents similar segmentation in other categories in the respective section.